🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, randomized, double-blind, placebo-controlled phase III clini...
Status
Unknown
Location
Shanghai Sixth People's Hospital
Start Date
2019-06-30
Trial ID
NCT05060406
Treatments Being Tested
A Dual-center , Randomized, double-blinded and Parallel-controlled Study to...
Status
Unknown
Location
Haikou People's Hospital
Start Date
2023-04-20
Trial ID
NCT05777109
This is a single-center, open-label, dose-escalating study to evaluate the ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2017-08-07
Trial ID
NCT03242512
Treatments Being Tested
This is a randomized, double-blind, international multicentre, parallel-con...
Status
Completed
Location
The First Hospital of Hebei Medical University
Start Date
2022-06-17
Trial ID
NCT05352516
This is a single-center, open-label, dose-escalating study to evaluate the ...
Status
Unknown
Location
the first affiliated hospital with Nanjing University
Start Date
2017-07-20
Trial ID
NCT03239756
Treatments Being Tested
A randomized, double-blind, two-group parallel, placebo-controlled clinical...
Status
Unknown
Location
Shanghai sixth people's hospital
Start Date
2019-06-05
Trial ID
NCT04128163
JMT103 is a novel, full human IgG4 monoclonal antibody targeting RANKL. In ...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2018-05-21
Trial ID
NCT03550508
Treatments Being Tested
This is a multicenter，randomized, double-blind, active-controlled, parallel...
Status
Unknown
Location
The First Affiliated Hospital of Guangdong Pharmaceutical University
Start Date
2021-04-30
Trial ID
NCT04859569
A multi-center, randomized, double-blind, comparative study to evaluate the...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-04-26
Trial ID
NCT04550949
This phase I trial studies the side effects and best dose of everolimus whe...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-06-19
Trial ID
NCT01624766
Treatments Being Tested